Literature DB >> 11167348

Calreticulin is an interleukin-3-sensitive calcium-binding protein in human basophil leukocytes.

J M Lyngholm1, H V Nielsen, M Holm, P O Schiøtz, A H Johnsen.   

Abstract

BACKGROUND: IL-3 enhances basophil histamine release upon stimulation with any known secretagogue. The molecular mechanism behind this regulation is not known, although some observations suggest that IL-3 modulates the calcium part of the signal transduction mechanism. The inhibitory action of glucocorticoids on basophils can be reversed by stimulation with IL-3.
METHODS: Calcium-binding proteins in the basophil cell line KU812 were identified by two-dimensional gel electrophoresis, Calcium-overlay assay, N-terminal sequence analysis, and mass spectometry. The presence of the same proteins in purified human basophil leukocytes was established by comigration of KU812 and human basophil proteins on the two-dimensional gels. The expression of the calcium-binding proteins in the absence and presence of IL-3 and/or anti-IgE was determined by densitometric measurement of the spots on the two-dimensional gels.
RESULTS: Calreticulin was identified on the two-dimensional gel of KU812 proteins. A protein with exactly the same migration pattern was found on the gels of proteins from purified human basophils. Immunoblotting with a specific antihuman calreticulin antibody confirmed that this protein was calreticulin. Subsequent analysis showed that the expression of calreticulin in the basophils is upregulated twofold upon stimulation with rhIL-3, even in doses below those needed for enhancement of histamine release.
CONCLUSIONS: The expression of calreticulin in human basophil leukocytes is regulated by IL-3. Calreticulin is known to modulate IP3-dependent Ca2+ influx in different cell systems, and calreticulin overexpression inhibits steroid-induced transcriptional activation. Therefore, modulation of calreticulin expression may be one mechanism by which IL-3 exerts its effects on human basophils.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11167348     DOI: 10.1034/j.1398-9995.2001.00115.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  3 in total

1.  Signaling pathways activated by a protease allergen in basophils.

Authors:  Rachel K Rosenstein; Jelena S Bezbradica; Shuang Yu; Ruslan Medzhitov
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-04       Impact factor: 11.205

2.  Evidence of pathway-specific basophil anergy induced by peanut oral immunotherapy in peanut-allergic children.

Authors:  A Thyagarajan; S M Jones; A Calatroni; L Pons; M Kulis; C S Woo; M Kamalakannan; B P Vickery; A M Scurlock; A Wesley Burks; W G Shreffler
Journal:  Clin Exp Allergy       Date:  2012-08       Impact factor: 5.018

3.  Thioredoxin Txnl1/TRP32 is a redox-active cofactor of the 26 S proteasome.

Authors:  Katrine M Andersen; Louise Madsen; Søren Prag; Anders H Johnsen; Colin A Semple; Klavs B Hendil; Rasmus Hartmann-Petersen
Journal:  J Biol Chem       Date:  2009-04-06       Impact factor: 5.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.